Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisa Ambrosi is active.

Publication


Featured researches published by Elisa Ambrosi.


Neuropsychobiology | 2011

Functional neuroimaging in obsessive-compulsive disorder.

A. Del Casale; Georgios D. Kotzalidis; Chiara Rapinesi; Daniele Serata; Elisa Ambrosi; Alessio Simonetti; Maurizio Pompili; Stefano Ferracuti; Roberto Tatarelli; Paolo Girardi

Background and Aim: Obsessive-compulsive disorder (OCD) is a severe, highly prevalent and chronically disabling psychiatric disorder that usually emerges during childhood or adolescence. This paper aims to review the literature on functional neuroimaging in OCD, analysing the reported dysfunctional connectivity in the corticostriatothalamocortical circuitry. Method: This study included papers published in peer-reviewed journals dealing with functional imaging in OCD. Results: Striatal dysfunction, mainly of the caudate nucleus, leads to inefficient thalamic gating, resulting in hyperactivity within the orbitofrontal cortex (intrusive thoughts) and the anterior cingulate cortex (non-specific anxiety). Compulsions consist of ritualistic behaviours performed to recruit the inefficient striatum and neutralise unwanted thoughts and anxiety. Functional neuroimaging findings are discussed against the background of specific cognitive impairments, mainly regarding visuospatial processing, executive functioning and motor speed. Cognitive deficits are partial and specific, matching imaging data. Conclusions: Several studies have targeted brain regions hypothesised to be involved in the pathogenesis of OCD, showing the existence of dysfunctional connectivity in the corticostriatothalamocortical circuitry. Improvements in spatial resolution of neuroimaging techniques may contribute to a better understanding of the neurocircuitry of OCD and other anxiety disorders.


Psychiatry and Clinical Neurosciences | 2011

Suicide in a large population of former psychiatric inpatients

Gabriele Sani; Leonardo Tondo; Athanasios Koukopoulos; Daniela Reginaldi; Giorgio D. Kotzalidis; Alexia E. Koukopoulos; Giovanni Manfredi; Lorenzo Mazzarini; Isabella Pacchiarotti; Alessio Simonetti; Elisa Ambrosi; Gloria Angeletti; Paolo Girardi; Roberto Tatarelli

Aims:  The aim of this study was to identify predictors of completed suicide in a wide sample of psychiatric inpatients receiving retrospective and prospective DSM‐IV diagnoses.


Current Neuropharmacology | 2013

Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways

Isabella Panaccione; Flavia Napoletano; Alberto Forte; Giorgio D. Kotzalidis; Antonio Del Casale; Chiara Rapinesi; Chiara Brugnoli; Daniele Serata; Federica Caccia; Ilaria Cuomo; Elisa Ambrosi; Alessio Simonetti; Valeria Savoja; Lavinia De Chiara; Emanuela Danese; Giovanni Manfredi; Delfina Janiri; Marta Motolese; Ferdinando Nicoletti; Paolo Girardi; Gabriele Sani

Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia. Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action. Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established. Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.


Journal of Affective Disorders | 2015

Childhood traumatic experiences of patients with bipolar disorder type i and type II

Delfina Janiri; Gabriele Sani; Emanuela Danese; Alessio Simonetti; Elisa Ambrosi; Gloria Angeletti; Denise Erbuto; Carlo Caltagirone; Paolo Girardi; Gianfranco Spalletta

BACKGROUND Childhood trauma is an important environmental stressor associated with bipolar disorders (BD). It is still not clear if it is differently distributed between BD I and BD II. Therefore, the aim of this research was to investigate the distribution patterns of childhood trauma in BD I and BD II. In this perspective, we also studied the relationship between childhood trauma and suicidality. METHODS We assessed 104 outpatients diagnosed with BD I (n=58) or BD II (n=46) according to DSM-IV-TR criteria and 103 healthy controls (HC) matched for age, sex and education level. History of childhood trauma was obtained using the Childhood Trauma Questionnaire (CTQ). RESULTS All patients with BD had had more severe traumatic childhood experiences than HC. Both BD I and BD II patients differed significantly from HC for trauma summary score and emotional abuse. BD I patients differed significantly from HC for sexual abuse, and BD II differed from HC for emotional neglect. BD I and BD II did not significantly differ for any type of trauma. Suicide attempts were linked to both emotional and sexual abuse in BD I and only to emotional abuse in BD II. Emotional abuse was an independent predictor of lifetime suicide attempts in BD patients. LIMITATIONS The reliability of the retrospective assessment of childhood trauma experiences with the CTQ during adulthood may be influenced by uncontrolled recall bias. CONCLUSIONS The assessment of childhood trauma, which has great clinical importance because of its strong link with suicidality, can unveil slight differences between BD subtypes and HC.


Journal of Affective Disorders | 2013

Structural brain alterations in bipolar disorder II: a combined voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) study.

Elisa Ambrosi; Maria Camilla Rossi-Espagnet; Georgios D. Kotzalidis; Anna Comparelli; Antonio Del Casale; Filippo Carducci; Andrea Romano; Giovanni Manfredi; Roberto Tatarelli; Alessandro Bozzao; Paolo Girardi

BACKGROUND Brain structural changes have been described in bipolar disorder (BP), but usually studies focused on both I and II subtypes indiscriminately and investigated changes in either brain volume or white matter (WM) integrity. We used combined voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) analysis to track changes in the grey matter (GM) and WM in the brains of patients affected by BPII, as compared to healthy controls. METHODS Using VBM and DTI, we scanned 20 DSM-IV-TR BPII patients in their euthymic phase and 21 healthy, age- and gender-matched volunteers with no psychiatric history. RESULTS VBM showed decreases in GM of BPII patients, compared to controls, which were diffuse in nature and most prominent in the right middle frontal gyrus and in the right superior temporal gurus. DTI showed significant and widespread FA reduction in BPII patients in all major WM tracts, including cortico-cortical association tracts. LIMITATIONS The small sample size limits the generalisability of our findings. CONCLUSIONS Reduced GM volumes and WM integrity changes in BPII patients are not prominent like those previously reported in bipolar disorder type-I and involve cortical structures and their related association tracts.


International Journal of Neuroscience | 2011

Personality Changes After Toscana Virus (TOSV) Encephalitis in a 49-Year-Old Man: A Case Report

Daniele Serata; Chiara Rapinesi; Antonio Del Casale; Alessio Simonetti; Lorenzo Mazzarini; Elisa Ambrosi; Giorgio D. Kotzalidis; Claudio Fensore; Paolo Girardi; Roberto Tatarelli

ABSTRACT Toscana virus (TOSV) infection may often cause symptomatic meningitides and encephalitides. These usually subside in few days and their sequelae do not last for more than few weeks. We here report the case of a 49-year-old man who developed encephalitis after being bitten by phlebotomi in a region near southern Tuscany, where TOSV is endemic, and who developed postencephalitic seizures and subsequently, persistent personality alterations, characterized by sexually dissolute behavior and aggressiveness. One year after infection, the patient needs a combination of an SSRI antidepressant and a mood stabilizer/anticonvulsant to obtain less than optimal symptom improvement. This points to the need of establishing better preventive measures in Tuscany and nearby regions.


Pharmaceuticals | 2010

Antidepressants and Suicide Risk: A Comprehensive Overview.

Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Elisa Ambrosi; Gloria Giordano; Paolo Girardi; Roberto Tatarelli; David Lester

The annual worldwide suicide rate currently averages approximately 13 per 100,000 individuals per year (0.013% per year), with higher average rates for men than for women in all but a few countries, very low rates in children, and relatively high rates in elderly men. Suicide rates vary markedly between countries, reflecting in part differences in case-identification and reporting procedures. Rates of attempted suicide in the general population average 20–30 times higher than rates of completed suicide, but are probably under-reported. Research on the relationship between pharmacotherapy and suicidal behavior was rare until a decade ago. Most ecological studies and large clinical studies have found that a general reduction in suicide rates is significantly correlated with higher rates of prescribing modern antidepressants. However, ecological, cohort and case-control studies and data from brief, randomized, controlled trials in patients with acute affective disorders have found increases, particularly in young patients and particularly for the risk of suicide attempts, as well as increases in suicidal ideation in young patients. whether antidepressants are associated with specific aspects of suicidality (e.g., higher rates of completed suicide, attempted suicide and suicidal ideation) in younger patients with major affective disorders remains a highly controversial question. In light of this gap this paper analyzes research on the relationship between suicidality and antidepressant treatment.


Journal of Affective Disorders | 2016

White matter microstructural characteristics in Bipolar I and Bipolar II Disorder: A diffusion tensor imaging study

Elisa Ambrosi; Chiara Chiapponi; Gabriele Sani; Giovanni Manfredi; Fabrizio Piras; Carlo Caltagirone; Gianfranco Spalletta

BACKGROUND Diffusion tensor imaging (DTI) studies of bipolar disorder (BD) report contrasting results and are mainly focused on bipolar I (BD-I) samples. We aimed at investigating how and where DTI parameters differ between BD-I and bipolar II (BD-II) and between BD and healthy control subjects (HC). METHODS We conducted a tract-based spatial statistics analysis of DTI derived parameters, namely fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD) in a matched sample of 50 BD (25 BD-I and 25 BD-II) during the chronic course of the illness and 50 HC. RESULTS Compared to BD-I and HC, BD-II showed lower FA but no significant AD or RD differences in the right inferior longitudinal fasciculus (ILF). Both patient groups showed lower AD and RD in the left internal capsule and lower AD across the left ILF, the cortico-spinal tract within the right hemisphere and bilaterally in the cerebellum with respect to HC. LIMITATIONS Patients were medicated at the time of scanning; the BD-II group had higher Hamilton Rating Scale for Depression scores than the BD-I group. CONCLUSIONS BD-II patients differ from BD-I in the ILF. Both BD subtypes showed widespread white matter (WM) changes in the internal capsule, cortico-spinal tract and cerebellum. The loss of WM integrity in BD-II might be due to demyelination whereas WM changes common to both subgroups could be attributable to axonal damage.


Bipolar Disorders | 2016

Gray and white matter trajectories in patients with bipolar disorder

Gabriele Sani; Chiara Chiapponi; Fabrizio Piras; Elisa Ambrosi; Alessio Simonetti; Emanuela Danese; Delfina Janiri; Roberto Brugnoli; Sergio De Filippis; Carlo Caltagirone; Paolo Girardi; Gianfranco Spalletta

Findings on brain structural abnormalities in patients with bipolar disorder (BP) are inconsistent and little is known about age‐related evolution of these changes. We employed a cross‐sectional, case–control study to compare structural age‐related brain trajectories in patients with BP and healthy control subjects (HC) over a period of approximately 50 years. The primary aim was to understand whether white (WM) and gray matter (GM) abnormalities are present from the beginning of the illness and how they change over time.


Journal of Clinical Psychopharmacology | 2013

Effectiveness of Short-Term Olanzapine in Patients With Bipolar-I Disorder, With or Without Comorbidity With Substance Use Disorder

Gabriele Sani; Georgios D. Kotzalidis; Paul A. Vöhringer; Daniela Pucci; Alessio Simonetti; Giovanni Manfredi; Valeria Savoja; Stefano Maria Tamorri; Lorenzo Mazzarini; Isabella Pacchiarotti; Carla Ludovica Telesforo; Stefano Ferracuti; Roberto Brugnoli; Elisa Ambrosi; Matteo Caloro; Antonio Del Casale; Alexia E. Koukopoulos; Derick Vergne; Paolo Girardi; S. Nassir Ghaemi

Objectives Prognosis of comorbid bipolar disorder (BD) and drug abuse is poor. We assessed the efficacy of olanzapine in manic or mixed BD patients, with (SUD) or without (N-SUD) comorbidity with substance use disorder (SUD) and its effect on drug abuse, days of abuse, and craving. Methods Eighty patients with BD-I (40 SUD) were hospitalized for a manic or mixed episode and received add-on olanzapine. Assessments were conducted at admission, discharge, and 4 and 8 weeks after discharge. Primary outcome was the proportion of responders and remitters in each group. We used a logistic regression model to adjust for possible confounders. We assessed craving and drug-abuse days with a visual analog scale and the Timeline Follow-Back. Results SUD and N-SUD were similar on response and remission, adjusted for sex, age, years ill, age at first episode, first episode depressive, number of hospitalizations, and duration of hospitalization (odds ratio, 1.09; 95% confidence interval, 1.02–2.29). Mood rating scores dropped significantly from baseline to end point in both groups. Timeline follow-back decreased in SUD from 22.5 to 7.3 at 8 weeks postdischarge, whereas craving dropped from 8.3 to 5.1 (P < 0.03). Conclusions The effectiveness of short-term olanzapine in BD-I mania or mixed mania did not differ according to SUD comorbidity. Treatment was followed by less substance use/abuse and craving in comorbid bipolar-SUD patients.

Collaboration


Dive into the Elisa Ambrosi's collaboration.

Top Co-Authors

Avatar

Alessio Simonetti

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Paolo Girardi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Gabriele Sani

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Roberto Tatarelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giovanni Manfredi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Antonio Del Casale

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Chiara Rapinesi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Delfina Janiri

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Gloria Angeletti

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge